Appearance of the pituitary factor Pit-1 increases chromatin remodeling at hypersensitive site III in the human GH locus.
Expression of pituitary and placental members of the human GH and chorionic somatomammotropin (CS) gene family is directed by an upstream remote locus control region (LCR). Pituitary-specific expression of GH requires direct binding of Pit-1 (listed as POU1F1 in the HUGO database) to sequences marked by a hypersensitive site (HS) region (HS I/II) 14.6 kb upstream of the GH-N gene (listed as GH1 in the HUGO database). We used human embryonic kidney 293 (HEK293) cells overexpressing wild-type and mutant Pit-1 proteins as a model system to gain insight into the mechanism by which Pit-1 gains access to the GH LCR. Addition of Pit-1 to these cells increased DNA accessibility at HS III, located 28 kb upstream of the human GH-N gene, in a POU homeodomain-dependent manner, as reflected by effects on histone hyperacetylation and RNA polymerase II activity. Direct binding of Pit-1 to HS III sequences is not supported. However, the potential for binding of ETS family members to this region has been demonstrated, and Pit-1 association with this ETS element in HS III sequences requires the POU homeodomain. Also, both ETS1 and ELK1 co-precipitate from human pituitary extracts using two independent sources of Pit-1 antibodies. Finally, overexpression of ELK1 or Pit-1 expression in HEK293 cells increased GH-N RNA levels. However, while ELK1 overexpression also stimulated placental CS RNA levels, the effect of Pit-1 appeared to correlate with ETS factor levels and target GH-N preferentially. These data are consistent with recruitment and an early role for Pit-1 in remodeling of the GH LCR at the constitutively open HS III through protein-protein interaction.
Yang
Xiaoyang
X
Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Jin
Yan
Y
Cattini
Peter A
PA
D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D042002:Chromatin Assembly and Disassembly; D005786:Gene Expression Regulation; D019382:Human Growth Hormone / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D019901:Locus Control Region; D008969:Molecular Sequence Data; D010902:Pituitary Gland / Q000378:metabolism; D012313:RNA / Q000235:genetics / Q000378:metabolism; D050817:Transcription Factor Pit-1 / Q000235:genetics / Q000378:metabolism*; D050807:ets-Domain Protein Elk-1 / Q000235:genetics / Q000378:metabolism
D050817:Transcription Factor Pit-1; D050807:ets-Domain Protein Elk-1; D019382:Human Growth Hormone; D012313:RNA
Mol Endocrinol. 2006 Mar;20(3):598-607
16239259
Genomics. 1989 May;4(4):479-97
2744760
Mol Endocrinol. 2004 Mar;18(3):574-87
14673137
Nucleic Acids Res. 2000 Jan 1;28(1):316-9
10592259
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5129-34
10220430
Mol Cell. 2006 Aug 4;23(3):365-75
16885026
EMBO J. 1987 Apr;6(4):971-81
3595566
J Biol Chem. 1993 Apr 25;268(12):8473-9
8473291
Genes Dev. 1991 Jul;5(7):1309-20
2065979
Placenta. 2009 Mar;30(3):226-35
19168217
Mol Cell. 2002 Feb;9(2):291-302
11864603
J Biol Chem. 2000 Feb 4;275(5):3100-6
10652292
Neuroendocrinology. 2006;83(3-4):145-53
17047377
J Biol Chem. 1999 Dec 10;274(50):35725-33
10585453
Science. 1992 Aug 21;257(5073):1115-8
1509262
Mol Cell Biol. 2006 Sep;26(17):6535-46
16914737
Mol Cell Biol. 1995 Dec;15(12):7010-21
8524268
Nucleic Acids Res. 1995 Dec 11;23(23):4878-84
8532532
Mol Cell Biol. 2007 Sep;27(18):6555-68
17636034
Nature. 1990 Oct 11;347(6293):528-33
1977085
EMBO Rep. 2008 Sep;9(9):891-8
18636089
EMBO J. 2000 Dec 15;19(24):6814-22
11118216
Trends Endocrinol Metab. 2007 May-Jun;18(4):150-8
17387021
Annu Rev Physiol. 1990;52:773-91
2184776
Mol Cell Biochem. 1991 Aug 14;106(2):181-7
1922020
Mol Cell Biol. 1997 Mar;17(3):1065-74
9032233
Trends Endocrinol Metab. 2004 Jan-Feb;15(1):40-5
14693425
Cell. 1990 Jun 15;61(6):1021-33
2350782
Mol Endocrinol. 1999 Aug;13(8):1249-66
10446901
Mol Endocrinol. 2003 Jun;17(6):1027-38
12624117
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10655-60
9724759
Mol Endocrinol. 2004 Apr;18(4):1018-32
14715931